137 related articles for article (PubMed ID: 2172401)
1. Treatment of condyloma acuminatum with three different interferon-alpha preparations administered parenterally: a double-blind, placebo-controlled trial.
Reichman RC; Oakes D; Bonnez W; Brown D; Mattison HR; Bailey-Farchione A; Stoler MH; Demeter LM; Tyring SK; Miller L
J Infect Dis; 1990 Dec; 162(6):1270-6. PubMed ID: 2172401
[TBL] [Abstract][Full Text] [Related]
2. Treatment of condyloma acuminatum with three different interferons administered intralesionally. A double-blind, placebo-controlled trial.
Reichman RC; Oakes D; Bonnez W; Greisberger C; Tyring S; Miller L; Whitley R; Carveth H; Weidner M; Krueger G
Ann Intern Med; 1988 May; 108(5):675-9. PubMed ID: 3358568
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled trial of systemically administered interferon-alpha, -beta, or -gamma in combination with cryotherapy for the treatment of condyloma acuminatum.
Bonnez W; Oakes D; Bailey-Farchione A; Choi A; Hallahan D; Pappas P; Holloway M; Corey L; Barnum G; Dunne A
J Infect Dis; 1995 May; 171(5):1081-9. PubMed ID: 7538546
[TBL] [Abstract][Full Text] [Related]
4. Recurrent condylomata acuminata treated with recombinant interferon alpha-2a. A multicenter double-blind placebo-controlled clinical trial. Condylomata International Collaborative Study Group.
Acta Derm Venereol; 1993 Jun; 73(3):223-6. PubMed ID: 8105627
[TBL] [Abstract][Full Text] [Related]
5. Intralesional interferon alfa-2b for the treatment of genital warts.
Welander CE; Homesley HD; Smiles KA; Peets EA
Am J Obstet Gynecol; 1990 Feb; 162(2):348-54. PubMed ID: 2155531
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of condylomata acuminata following cryotherapy is not prevented by systemically administered interferon.
Eron LJ; Alder MB; O'Rourke JM; Rittweger K; DePamphilis J; Pizzuti DJ
Genitourin Med; 1993 Apr; 69(2):91-3. PubMed ID: 8509099
[TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trial comparing systemic interferon with diathermocoagulation in primary multiple and widespread anogenital condyloma.
Benedetti Panici P; Scambia G; Baiocchi G; Perrone L; Pintus C; Mancuso S
Obstet Gynecol; 1989 Sep; 74(3 Pt 1):393-7. PubMed ID: 2761917
[TBL] [Abstract][Full Text] [Related]
8. Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris.
Vance JC; Bart BJ; Hansen RC; Reichman RC; McEwen C; Hatch KD; Berman B; Tanner DJ
Arch Dermatol; 1986 Mar; 122(3):272-7. PubMed ID: 3954392
[TBL] [Abstract][Full Text] [Related]
9. Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum.
Monsonego J; Cessot G; Ince SE; Galazka AR; Abdul-Ahad AK
Genitourin Med; 1996 Apr; 72(2):111-4. PubMed ID: 8698357
[TBL] [Abstract][Full Text] [Related]
10. Interferon therapy for condylomata acuminata.
Eron LJ; Judson F; Tucker S; Prawer S; Mills J; Murphy K; Hickey M; Rogers M; Flannigan S; Hien N
N Engl J Med; 1986 Oct; 315(17):1059-64. PubMed ID: 3531860
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the antibody response to human papillomavirus type 11 (HPV-11) in patients with condyloma acuminatum according to treatment response.
Bonnez W; Da Rin C; Rose RC; Tyring SK; Reichman RC
J Med Virol; 1993 Apr; 39(4):340-4. PubMed ID: 8388030
[TBL] [Abstract][Full Text] [Related]
12. Intralesional interferon alfa-2b treatment of condylomata acuminata previously resistant to podophyllum resin application.
Boot JM; Blog FB; Stolz E
Genitourin Med; 1989 Jan; 65(1):50-3. PubMed ID: 2921053
[TBL] [Abstract][Full Text] [Related]
13. Recurrent condylomata acuminata treated with recombinant interferon alfa-2a. A multicenter double-blind placebo-controlled clinical trial. Condylomata International Collaborative Study Group.
JAMA; 1991 May 22-29; 265(20):2684-7. PubMed ID: 2023348
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind trial of parenteral low dose versus high dose interferon-beta in combination with cryotherapy for treatment of condyloma acuminatum.
Bonnez W; Oakes D; Bailey-Farchione A; Choi A; Hallahan D; Corey L; Barnum G; Pappas PG; Halloway M; Stoler MH; Reichman RC
Antiviral Res; 1997 Jun; 35(1):41-52. PubMed ID: 9224960
[TBL] [Abstract][Full Text] [Related]
15. Recombinant interferon alpha-2A (Roferon-A) in a case of Buschke-Löwenstein giant condyloma.
Zachariae H; Larsen PM; Søgaard H
Dermatologica; 1988; 177(3):175-9. PubMed ID: 3169343
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomised observer blind placebo controlled study.
Handley JM; Horner T; Maw RD; Lawther H; Dinsmore WW
Genitourin Med; 1991 Aug; 67(4):297-302. PubMed ID: 1916791
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of combination therapy with intralesional interferon alpha 2b and podophyllin versus podophyllin alone for the therapy of anogenital warts.
Douglas JM; Eron LJ; Judson FN; Rogers M; Alder MB; Taylor E; Tanner D; Peets E
J Infect Dis; 1990 Jul; 162(1):52-9. PubMed ID: 2192011
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of human lymphoblastoid interferon in the therapy of resistant condyloma acuminata.
Gall SA; Hughes CE; Mounts P; Segriti A; Weck PK; Whisnant JK
Obstet Gynecol; 1986 May; 67(5):643-51. PubMed ID: 3008054
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human interferon-beta for condylomata acuminata: a randomized, double-blind, placebo-controlled study of intralesional therapy.
Bornstein J; Pascal B; Zarfati D; Goldshmid N; Abramovici H
Int J STD AIDS; 1997 Oct; 8(10):614-21. PubMed ID: 9310220
[TBL] [Abstract][Full Text] [Related]
20. Randomized placebo-controlled double-blind combined therapy with laser surgery and systemic interferon-alpha 2a in the treatment of anogenital condylomata acuminatum. The Condylomata International Collaborative Study Group.
J Infect Dis; 1993 Apr; 167(4):824-9. PubMed ID: 8450247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
